We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. WASHINGTON — MELD 3.0 more accurately predicted the risk ...
Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...
Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...
SAN DIEGO — Since the adoption of the most recent Model for End-Stage Liver Disease (MELD 3.0) scoring system by the federal Organ Procurement and Transplantation Network (OPTN) in July 2023, the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Waitlist survival at 90 days improved from 86.5% before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback